Status | Study |
NOT_YET_RECRUITING |
Study Name: Open Label Trial of Oral Letermovir for CMV Prophylaxis in Thoracic Transplant Recipients Condition: Cytomegalovirus Infections Date: 2023-09-13 Interventions: Letermovir for CMV prophylaxis in thoracic organ transplant recipients.Letermovir will be administered by oral administration, as per study |
RECRUITING |
Study Name: Letermovir for Secondary Prophylaxis in Solid Organ Transplant Recipients Condition: Cytomegalovirus Infections Date: 2022-11-15 Interventions: Open label 480 mg given daily for 60 days |
Recruiting |
Study Name: CMV-CTL for the Treatment of CMV Infection After HSCT Condition: Cytomegalovirus Infections Hematological Disease Date: 2016-12-18 Interventions: Biological: CMV-CTL donor deri |
Recruiting |
Study Name: A Cross-sectional Study of Congenital Cytomegalovirus Infection in Newborns in China Condition: Congenital Cytomegalovirus Infection Date: 2016-03-05 |
Enrolling by invitation |
Study Name: Screening for Congenital Cytomegalovirus Infection in Newborns Condition: Cytomegalovirus Infections Date: 2016-02-11 Interventions: Other: Observation Viable Infants with a failed hearing screen or a diagnosis of SGA who are born at eit |
Recruiting |
Study Name: Conversion to Sirolimus: Effects in Cytomegalovirus Infection Recurrence Condition: Cytomegalovirus Infections Date: 2016-01-26 Interventions: Drug: Drug conversion to sirolimus |
Recruiting |
Study Name: Analysis of CMV Infections in Patients With Brain Tumors or Brain Metastases During and After Radio(Chemo)Therapy Condition: Cytomegalovirus Infections Date: 2015-10-23 Interventions: Other: Blood draw and MRI The study is observational. The treatment-plan of the underlying disease remai |
Completed |
Study Name: A Study of MCMV5322A/MCMV3068A for the Prevention of Cytomegalovirus Disease in High-Risk Kidney Allograft Recipients Condition: Cytomegalovirus Infections Date: 2012-12-17 Interventions: Drug: MCMV3068A Four doses of |
Completed |
Study Name: Maribavir for Treatment of Resistant or Refractory CMV Infections in Transplant Recipients Condition: Cytomegalovirus Infections Date: 2012-06-01 Interventions: Drug: Maribavir Tablet for oral administration |
Recruiting |
Study Name: Evaluation of the PK and PD of Ganciclovir in Premature Infants Receiving Treatment for CMV Infection Condition: Cytomegalovirus Infections Date: 2012-05-17 |